Search research articles
Contact Us
Filters
Showing results (751-760 of 3,130) with videos related to
Page
of 313
Sort By:
Current Research in Pharmacology and Drug Discovery
|
July 14, 2023
A PAM of the α<sub>1A</sub>-Adrenergic receptor rescues biomarker, long-term potentiation, and cognitive deficits in Alzheimer's disease mouse models without effects on blood pressure
Robert S Papay, Shaun R Stauffer, Dianne M Perez
Frontiers in Neuroscience
|
April 8, 2026
Inflammatory biomarker outcomes associated with MDMA-assisted therapy: an open-label exploratory study
Jenna E Kachmarik, Jennifer M Loftis, Christopher S Stauffer
Journal of Biomolecular NMR
|
June 14, 2002
Refinement of the solution structure of the heparin-binding domain of vascular endothelial growth factor using residual dipolar couplings
Melissa E Stauffer, Nicholas J Skelton, Wayne J Fairbrothe
Archives of Surgery (Chicago, Ill. : 1960)
|
June 1, 1975
The MacIntosh prosthesis. Prospective clinical and gait evaluation
R Stauffer, D B Kettelkamp, C Thompson, et al.
The American Journal of Tropical Medicine and Hygiene
|
February 3, 2021
Critical Considerations for COVID-19 Vaccination of Refugees, Immigrants, and Migrants
Christine M Thomas, Michael T Osterholm, William M Stauffer
The New England Journal of Medicine
|
July 1, 2008
Hypereosinophilic syndrome and mepolizumab
David R Boulware, William M Stauffer, Patricia F Walker
Journal of Hypertension
|
February 24, 2022
Nebivolol and incident cardiovascular events in hypertensive patients compared with nonvasodilatory beta blockers
Daniel M Huck, Michael A Rosenberg, Brian L Stauffer
Microbiology (Reading, England)
|
November 7, 2000
GcvA binding site 1 in the gcvTHP promoter of Escherichia coli is required for GcvA-mediated repression but not for GcvA-mediated activation
Laura D Wonderling, Mark L Urbanowski, George V Stauffer
Epidemiology and Infection
|
September 12, 2000
Drug resistance rates of Mycobacterium tuberculosis strains in Austria between 1995 and 1998 and molecular typing of multidrug-resistant isolates. The Austrian Drug Resistant Tuberculosis Study Group
F Stauffer, A Makristathis, J P Klein, et al.
Journal of Bacteriology
|
September 1, 1995
DNA binding sites of the LysR-type regulator GcvA in the gcv and gcvA control regions of Escherichia coli
R L Wilson, M L Urbanowski, G V Stauffer
Page
of 313
Search research articles
Search
Showing results (751-760 of 3,130) with videos related to
Sort By:
Page
of 313
Current Research in Pharmacology and Drug Discovery
|
July 14, 2023
A PAM of the α<sub>1A</sub>-Adrenergic receptor rescues biomarker, long-term potentiation, and cognitive deficits in Alzheimer's disease mouse models without effects on blood pressure
Robert S Papay, Shaun R Stauffer, Dianne M Perez
Frontiers in Neuroscience
|
April 8, 2026
Inflammatory biomarker outcomes associated with MDMA-assisted therapy: an open-label exploratory study
Jenna E Kachmarik, Jennifer M Loftis, Christopher S Stauffer
Journal of Biomolecular NMR
|
June 14, 2002
Refinement of the solution structure of the heparin-binding domain of vascular endothelial growth factor using residual dipolar couplings
Melissa E Stauffer, Nicholas J Skelton, Wayne J Fairbrothe
Archives of Surgery (Chicago, Ill. : 1960)
|
June 1, 1975
The MacIntosh prosthesis. Prospective clinical and gait evaluation
R Stauffer, D B Kettelkamp, C Thompson, et al.
The American Journal of Tropical Medicine and Hygiene
|
February 3, 2021
Critical Considerations for COVID-19 Vaccination of Refugees, Immigrants, and Migrants
Christine M Thomas, Michael T Osterholm, William M Stauffer
The New England Journal of Medicine
|
July 1, 2008
Hypereosinophilic syndrome and mepolizumab
David R Boulware, William M Stauffer, Patricia F Walker
Journal of Hypertension
|
February 24, 2022
Nebivolol and incident cardiovascular events in hypertensive patients compared with nonvasodilatory beta blockers
Daniel M Huck, Michael A Rosenberg, Brian L Stauffer
Microbiology (Reading, England)
|
November 7, 2000
GcvA binding site 1 in the gcvTHP promoter of Escherichia coli is required for GcvA-mediated repression but not for GcvA-mediated activation
Laura D Wonderling, Mark L Urbanowski, George V Stauffer
Epidemiology and Infection
|
September 12, 2000
Drug resistance rates of Mycobacterium tuberculosis strains in Austria between 1995 and 1998 and molecular typing of multidrug-resistant isolates. The Austrian Drug Resistant Tuberculosis Study Group
F Stauffer, A Makristathis, J P Klein, et al.
Journal of Bacteriology
|
September 1, 1995
DNA binding sites of the LysR-type regulator GcvA in the gcv and gcvA control regions of Escherichia coli
R L Wilson, M L Urbanowski, G V Stauffer
Page
of 313